{"disease":{"id":"endometriosis","name":"Endometriosis","therapeutic_area":"Women\\","data":{"aiSummary":"The treatment landscape for endometriosis includes hormonal therapies, pain management, and surgical interventions. Marketed options include GnRH agonists and combined oral contraceptives. Recent advances include the approval of MYFEMBREE. The pipeline includes GnRH antagonists and other hormonal therapies, with a focus on improving pain relief and reducing the need for surgery.","drug_count":4,"description":"Endometriosis is a chronic, estrogen-dependent inflammatory condition characterized by the growth of endometrial-like tissue outside the uterus. This ectopic tissue responds to hormonal changes, leading to pain, inflammation, and the formation of adhesions. The current treatment landscape focuses on pain management, hormonal suppression, and surgical intervention.","subtype_count":7},"enrichment_level":2,"last_enriched_at":null,"visit_count":0,"created_at":"2026-03-25T12:16:34.924Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":22,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"elagolix","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Orilissa","generic_name":"ELAGOLIX","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor","drug_class":"Gonadotropin Releasing Hormone Receptor Antagonist","quality_score":66,"revenue":"600","mechanism":"Orilissa blocks the hormone signals that stimulate the growth of endometrial tissue."},{"drug_id":"relugolix","indication_name":"Pain associated with endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Orgovyx","generic_name":"relugolix","company_name":"MYOVANT SCIENCES","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor","drug_class":"Gonadotropin Releasing Hormone Receptor Antagonist [EPC]","quality_score":72,"revenue":"421","mechanism":"Relugolix is a nonpeptide GnRH receptor antagonist that competitively binds to pituitary GnRH receptors."},{"drug_id":"norethisterone","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Micronor","generic_name":"norethisterone","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"GnRH receptors","drug_class":"Progestin","quality_score":63,"revenue":null,"mechanism":"ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects."},{"drug_id":"norethynodrel","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noretynodrel","generic_name":"NORETHYNODREL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"norethynodrel","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"norethindrone-acetate","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aygestin","generic_name":"NORETHINDRONE ACETATE","company_name":"Duramed Res","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"Estrogen [EPC]","quality_score":46,"revenue":null,"mechanism":""},{"drug_id":"nafarelin","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Synarel","generic_name":"NAFARELIN","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor","drug_class":"Gonadotropin Releasing Hormone Receptor Agonist","quality_score":48,"revenue":null,"mechanism":""},{"drug_id":"medroxyprogesterone","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Depo-Provera","generic_name":"medroxyprogesterone","company_name":"Pfizer","drug_phase":"discontinued","molecular_target":"Progesterone receptor","drug_class":"Progestin","quality_score":null,"revenue":null,"mechanism":"Depo-Provera works by binding to the progesterone receptor in the body, which helps to regulate the menstrual cycle and prevent pregnancy."},{"drug_id":"goserelin","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zoladex","generic_name":"goserelin","company_name":"Tersera","drug_phase":"marketed","molecular_target":"pituitary gonadotropin secretion","drug_class":"Gonadotropin Releasing Hormone Receptor Agonist","quality_score":54,"revenue":null,"mechanism":"ZOLADEX inhibits pituitary gonadotropin secretion, leading to regression or inhibition of hormonally sensitive tumors."},{"drug_id":"goserelin-acetate","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zoladex","generic_name":"GOSERELIN ACETATE","company_name":"Tersera","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor","drug_class":"Gonadotropin Releasing Hormone Receptor Agonist","quality_score":54,"revenue":null,"mechanism":"Zoladex works by mimicking the body's natural hormone to reduce testosterone production."},{"drug_id":"leuprolide","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lupron","generic_name":"leuprolide","company_name":"Accord Healthcare S.L.U.","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor","drug_class":"Gonadotropin Releasing Hormone Receptor Agonist","quality_score":75,"revenue":null,"mechanism":"Lupron works by binding to and activating the gonadotropin-releasing hormone receptor, which ultimately leads to a decrease in the production of sex hormones."},{"drug_id":"danazol","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Danzol","generic_name":"DANAZOL","company_name":"","drug_phase":"marketed","molecular_target":"Sex hormone-binding globulin","drug_class":"Androgen [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"chlormadinone","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Menstridyl","generic_name":"chlormadinone","company_name":"","drug_phase":"unknown","molecular_target":"Glucocorticoid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Menstridyl works by blocking the action of cortisol, a hormone involved in the menstrual cycle."},{"drug_id":"endometrin","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Endometrin","generic_name":"progesterone","company_name":"Ferring","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1","drug_class":"Progesterone [EPC]","quality_score":27,"revenue":null,"mechanism":null},{"drug_id":"tranexamic-acid","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cyklokapron","generic_name":"TRANEXAMIC ACID","company_name":"Exela Pharma","drug_phase":"marketed","molecular_target":"Plasminogen","drug_class":"Antifibrinolytic Agent [EPC]","quality_score":80,"revenue":null,"mechanism":"Tranexamic acid works by binding to plasminogen and preventing its conversion to plasmin, thereby inhibiting fibrinolysis."},{"drug_id":"leuprolide-acetate","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Leuprolide Acetate","generic_name":"leuprolide-acetate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor","drug_class":"leuprorelin","quality_score":80,"revenue":null,"mechanism":"Leuprolide acetate is a manufactured version of a hormone that regulates growth and development, used to treat hormone-related conditions."},{"drug_id":"mestranol","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norinyl 1+50 28-Day","generic_name":"MESTRANOL","company_name":"","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"eligard","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Eligard","company_name":"Astellas Pharma Europe Ltd.","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor, Gonadotropin-releasing hormone receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"progesteron","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Progesteron","company_name":"Minia University","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"zoladex","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zoladex","company_name":"University of Michigan Rogel Cancer Center","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor, Lutropin-choriogonadotropic hormone receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"amchafibrin","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Amchafibrin","company_name":"Fundación Pública Andaluza Progreso y Salud","drug_phase":"phase_3","molecular_target":"Plasminogen","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"transamin","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"transamin","company_name":"Erzincan Military Hospital","drug_phase":"phase_3","molecular_target":"Plasminogen","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"orilissa","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Orilissa","company_name":"University of Wisconsin, Madison","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor, Gonadotropin-releasing hormone receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"nafarelin","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Synarel","generic_name":"NAFARELIN","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor","drug_class":"Gonadotropin Releasing Hormone Receptor Agonist","quality_score":48,"revenue":null,"mechanism":""},{"drug_id":"leuprorelin","indication_name":"Endometriosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lupron","generic_name":"leuprorelin","company_name":"Accord Healthcare S.L.U.","drug_phase":"marketed","molecular_target":"GnRH receptors","drug_class":"Gonadotropin Releasing Hormone Receptor Agonist","quality_score":65,"revenue":null,"mechanism":"Leuprolide acetate, a long-acting GnRH analog, initially stimulates then suppresses pituitary gonadotropins, reducing gonadal steroid secretion."}],"pipeline":[{"drug_id":"norethindrone","indication_name":"Endometriosis","indication_type":"pipeline","phase":"Phase 3","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NORETHINDRONE","company_name":"","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"Estrogen [EPC]","quality_score":60,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":24,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT01267851","title":"Clinical Database and Biobank of Patients With Gynecologic Neoplasms","phase":"","overall_status":"UNKNOWN","enrollment_count":1600000,"lead_sponsor_name":"Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT06217315","title":"Endometriosis and Health Care System Utilization in British Columbia","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"BC Women's Hospital & Health Centre","has_results":false},{"nct_id":"NCT03285230","title":"The French E3N Prospective Cohort Study","phase":"","overall_status":"UNKNOWN","enrollment_count":100000,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT01266421","title":"Visanne Post-approval Observational Study (VIPOS)","phase":"","overall_status":"COMPLETED","enrollment_count":27840,"lead_sponsor_name":"Center for Epidemiology and Health Research, Germany","has_results":false},{"nct_id":"NCT04806620","title":"Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Brain Inflammation Collaborative","has_results":false},{"nct_id":"NCT06147687","title":"Machine Learning for Early Diagnosis of Endometriosis(MLEndo)","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Semmelweis University","has_results":false},{"nct_id":"NCT03778359","title":"Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT06753162","title":"Oral Health and Endometriosis: A Cohort Study","phase":"","overall_status":"COMPLETED","enrollment_count":4079,"lead_sponsor_name":"University of Bari Aldo Moro","has_results":false},{"nct_id":"NCT06472765","title":"Vaginal Ecosystem and Network in the United States Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3250,"lead_sponsor_name":"Vaginal Biome Science","has_results":false},{"nct_id":"NCT01788722","title":"Regulatory Post Marketing Surveillance Study in Korea","phase":"","overall_status":"COMPLETED","enrollment_count":3223,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05682690","title":"Laparoscopic Eradication of Deep Endometriosis With Nerve-sparing Rectosigmoid Segmental Resection (RSRES_NERVSP)","phase":"","overall_status":"COMPLETED","enrollment_count":3072,"lead_sponsor_name":"IRCCS Sacro Cuore Don Calabria di Negrar","has_results":false},{"nct_id":"NCT06794424","title":"Impact of Ziwig Endotest® on the Management of Patients With Clinical Symptoms of Endometriosis Inconsistent With Their Imaging Work-up","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2503,"lead_sponsor_name":"ZIWIG","has_results":false},{"nct_id":"NCT04916171","title":"Determination of the Incidence of Endometriosis and or Adenomyosis in Patients Diagnosed With Polycystic Ovary Syndrome, or the Incidence of Polycystic Ovary Syndrome in Patients Diagnosed With Endometriosis and or Adenomyosis","phase":"","overall_status":"UNKNOWN","enrollment_count":2450,"lead_sponsor_name":"Kanuni Sultan Suleyman Training and Research Hospital","has_results":false},{"nct_id":"NCT07304245","title":"The Asymmetry Distribution of Endometriotic Lesions: Italian Multicenter Study","phase":"","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT04171297","title":"Ultrasound Evaluation of the Pelvis in Women with Suspected Endometriosis Scheduled for Laparoscopic Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":1866,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT04664335","title":"Impact of Endometriosis on Pregnancy and Delivery - a Retrospective Cohort Study","phase":"","overall_status":"COMPLETED","enrollment_count":1762,"lead_sponsor_name":"University Hospital Muenster","has_results":false},{"nct_id":"NCT00849173","title":"Global Study of Women's Health","phase":"","overall_status":"COMPLETED","enrollment_count":1459,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT02498691","title":"Perinatal Consequences of Endometriosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":1444,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03899935","title":"Laparoscopy for Endometriosis in Obese Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1230,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT05245695","title":"Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Aspira Women's Health","has_results":false},{"nct_id":"NCT05244668","title":"Multicenter Validation of the Salivary miRNA Signature of Endometriosis","phase":"","overall_status":"COMPLETED","enrollment_count":1140,"lead_sponsor_name":"ZIWIG","has_results":false},{"nct_id":"NCT07519213","title":"Postoperative Hormonal Therapy and Recurrence After Surgery for Ovarian Endometrioma","phase":"","overall_status":"COMPLETED","enrollment_count":1121,"lead_sponsor_name":"Guangdong Women and Children Hospital","has_results":false},{"nct_id":"NCT05239871","title":"Indirect Ultrasonographic Findings for Parametrial Involvement in Deep Endometriosis","phase":"","overall_status":"COMPLETED","enrollment_count":1078,"lead_sponsor_name":"Simone Ferrero","has_results":false},{"nct_id":"NCT07240883","title":"ENDO1000 - A UK-wide Endometriosis Research Project","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT05086484","title":"Omics Sequencing of Specimen Derived From Patients With Endometriosis","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Zhujiang Hospital","has_results":false},{"nct_id":"NCT04401592","title":"The Role of Galectins in the Non-invasive Diagnosis of Endometriosis","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Semmelweis University","has_results":false},{"nct_id":"NCT03376451","title":"EndoSearch : Endometriosis Biomarkers","phase":"NA","overall_status":"UNKNOWN","enrollment_count":975,"lead_sponsor_name":"Dr Afchine Fazel","has_results":false},{"nct_id":"NCT04495855","title":"A Study to Learn More About Using Dienogest to Treat Endometriosis in Chinese Participants","phase":"","overall_status":"COMPLETED","enrollment_count":968,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT01767090","title":"A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":912,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":false},{"nct_id":"NCT02425462","title":"To Evaluate Effectiveness of Visanne in Improving Quality of Life in Asian Women With Endometriosis","phase":"","overall_status":"COMPLETED","enrollment_count":895,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04862000","title":"Observational Study of Patients Suffering From Endometriosis and Adenomyosis","phase":"","overall_status":"RECRUITING","enrollment_count":880,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT01620528","title":"A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":872,"lead_sponsor_name":"AbbVie (prior sponsor, Abbott)","has_results":true},{"nct_id":"NCT03354793","title":"Endometriosis and Risk of Obstetric Complications","phase":"","overall_status":"COMPLETED","enrollment_count":844,"lead_sponsor_name":"Endometriosis Treatment Italian Club","has_results":false},{"nct_id":"NCT03354780","title":"Endometriosis and Risk of Miscarriage","phase":"","overall_status":"COMPLETED","enrollment_count":844,"lead_sponsor_name":"Endometriosis Treatment Italian Club","has_results":false},{"nct_id":"NCT00001850","title":"Evaluation of Women With Endocrine and Reproductive-Related Conditions","phase":"","overall_status":"TERMINATED","enrollment_count":833,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT01931670","title":"A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":815,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03654274","title":"SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":802,"lead_sponsor_name":"Myovant Sciences GmbH","has_results":true},{"nct_id":"NCT05754190","title":"Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Brown University","has_results":false},{"nct_id":"NCT05624567","title":"Symptoms and Quality of Life of Patients With Suspected Endometriosis","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT04001244","title":"Translational Research in Pelvic Pain","phase":"","overall_status":"COMPLETED","enrollment_count":787,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT04399668","title":"Comparison of Ultrasound-determined and Intraoperative #Enzian-classification in Patients With Deep Endometriosis","phase":"","overall_status":"COMPLETED","enrollment_count":745,"lead_sponsor_name":"Univ.-Doz. Dr.med.univ. Gernot Hudelist, MSc.","has_results":false},{"nct_id":"NCT04218487","title":"Xuefu-Zhuyu Capsule for the Treatment of \"Qizhi Xueyu Zheng\" (Qi Stagnation and Blood Stasis Syndrome)","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":720,"lead_sponsor_name":"Zhong Wang","has_results":false},{"nct_id":"NCT03126747","title":"Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea","phase":"","overall_status":"COMPLETED","enrollment_count":715,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03213457","title":"A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":681,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03744507","title":"Bone Mineral Density in Women With Uterine Fibroids or Endometriosis","phase":"","overall_status":"COMPLETED","enrollment_count":660,"lead_sponsor_name":"Myovant Sciences GmbH","has_results":false},{"nct_id":"NCT07437742","title":"Reproductive Prognosis in Women Seeking Offspring After Medical or Surgical Therapy for Endometriosis","phase":"","overall_status":"RECRUITING","enrollment_count":650,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT03204318","title":"SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":638,"lead_sponsor_name":"Myovant Sciences GmbH","has_results":false},{"nct_id":"NCT03204331","title":"SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":623,"lead_sponsor_name":"Myovant Sciences GmbH","has_results":false},{"nct_id":"NCT06072287","title":"The Living With a Long-Term Condition Study","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT06426420","title":"Endometriosis and ATR-FTIR Spectroscopy","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Federal University of Espirito Santo","has_results":false}],"total":50},"guidelines":[{"drug_id":"leuprorelin","guideline_body":"FDA label","recommendation":"LUPRON DEPOT 3.75 mg is indicated for management of endometriosis, including pain relief and reduction of endometriotic lesions. It can also be used in combination with norethindrone acetate for initial management of the painful symptoms of endometriosis and for management of recurrence of symptoms.","line_of_therapy":"1L","evidence_grade":"not specified","guideline_year":null}],"source":"Drug Landscape verified database"}